Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • Missouri Technology Expo (MU)
    • Missouri Technology Expo 2010 (MU)
    • Abstracts (Missouri Technology Expo 2010)
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • Missouri Technology Expo (MU)
    • Missouri Technology Expo 2010 (MU)
    • Abstracts (Missouri Technology Expo 2010)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    Compounds and methods for optical imaging of myeloperoxidase activity in vivo [abstract]

    Piwnica-Worms, David Rolland, 1956-
    View/Open
    [PDF] CompoundsMethodsOptical[abstract].pdf (37.02Kb)
    Date
    2010-10
    Format
    Abstract
    Metadata
    [+] Show full item record
    Abstract
    The invention relates to novel diagnostic methods for functionally assessing the presence of myeloperoxidase (MPO) activity in living subjects, including model organisms, animals and humans. While MPO is central to normal host defense mechanisms, dysregulated MPO contributes to the pathogenesis of inflammatory disease states ranging from atherosclerosis to cancer. We show that upon systemic administration, the small molecule luminol and related analogues enable noninvasive, specific and highly sensitive bioluminescence imaging (BLI) of MPO activity in vivo. This can be used to assess the risk of a subject for development of a pathological condition associated with high levels of oxidative stress, in particular, cardiovascular disease. In addition, methods are described for monitoring the effectiveness of therapy in a subject, and for establishing a prognosis in a subject undergoing treatment for a condition such as a cardiac condition, using non-invasive imaging to assess MPO activity in vivo as a specific marker of oxidative stress and as an indicator of disease progression or inhibition thereof. Potential Areas of Applications: * Cardiovascular * Imaging Patent Status: Pending Inventor(s): David Piwnica-Worms, MD, PhD Contact Info: Jon Kratochvil, Esq. kratochj@wustl.edu (314) 747-0923
    URI
    http://hdl.handle.net/10355/9714
    Part of
    Abstracts (Missouri Technology Expo 2010)
    Collections
    • Abstracts (Missouri Technology Expo 2010)

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems